Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CORTEX Biophysik GmbH, commonly branded as CORTEX, is a private German medical device company focused on cardiopulmonary exercise testing, spiroergometry, pulmonary function testing, and metabolic performance diagnostics. The company develops, manufactures, and sells portable and mobile diagnostic systems used across cardiology, pulmonology, rehabilitation, occupational medicine, research, and sports performance settings. Its core commercial product lines include METALYZER, METAMAX, and the MetaSoft Studio software environment that supports test execution, data acquisition, and analysis. CORTEX markets itself as a global leader in mobile spiroergometry and serves hospitals, universities, professional sports organizations, and research users worldwide. The business appears to be fully commercial rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cortex Biophysik.